Multiple-unit and second transfusions of red cells enzymatically converted from group B to group O: report on the end of phase 1 trials

Transfusion
L L LennyR A Galbraith

Abstract

It has previously been shown that 1 and 2 units (200 - 400 mL) of red cells (RBCs) enzymatically converted from group B to group O by treatment with alpha-galactosidase (ECO RBCs) are safe and efficacious when transfused to normal group O or A persons. The current report describes studies in which 1) normal group A and O subjects received large volumes of these cells (3 units), 2) some group O subjects underwent transfusion several months later, and 3) ECO RBCs were prepared by the use of recombinant coffee bean alpha-galactosidase and transfused to a group O subject, to demonstrate the in vivo equivalence of ECO RBCs, whether prepared with native or recombinant alpha-galactosidase. Clinical evaluation (hematologic tests, chemistry analysis, urinalysis) and serologic analyses did not reveal any evidence of subtle or acute transfusion reaction or significant increase in preexisting anti-B titer. ECO RBC survival within the circulation of the recipients was normal (24-hour survival, 95.5 +/- 0.9%; t1/2, 34.7 +/- 6.1 days; n = 8 transfusions), and the efficacy of the transfusions was manifested in elevations in recipient hemoglobin and hematocrit (hemoglobin increase, 1.5 +/- 0.6 g/dL; hematocrit increase, 3.6 +/- 1.6%; n = 8 tran...Continue Reading

Citations

Jan 24, 2004·Surgery·Jay DoucetVivian C McAlister
Feb 26, 2004·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·Martin L OlssonMargot S Kruskall
Dec 2, 2000·Transfusion·D M Lublin
Aug 15, 1998·Vox Sanguinis·W G van Aken
Jan 6, 2000·Archives of Biochemistry and Biophysics·E Maranville, A Zhu
Feb 7, 1998·Proceedings of the National Academy of Sciences of the United States of America·N OsmanM S Sandrin
Sep 29, 2011·Transfusion Medicine Reviews·Fumiichiro YamamotoAntoine Blancher
Jun 24, 2004·Vox Sanguinis·M L Olsson
Nov 1, 2007·British Journal of Haematology·Martin L Olsson, Henrik Clausen
Jan 8, 2011·British Journal of Haematology·Claude BagnisPascal Bailly
Aug 1, 2015·Therapeutic Delivery·Carlos H VillaVladimir R Muzykantov
Aug 23, 2018·Health Promotion Practice·Dale Ainsworth, Julie A Chesley
Nov 26, 2002·Hematology·George GarrattyLawrence D Petz
Feb 26, 2000·European Journal of Biochemistry·E Maranville, A Zhu
Jun 13, 2019·Enzyme Research·Thomas J Malinski, Harkewal Singh
Dec 4, 2019·The Journal of Biological Chemistry·Peter Rahfeld, Stephen G Withers
Aug 26, 2009·Langmuir : the ACS Journal of Surfaces and Colloids·Sania MansouriMaryam Tabrizian

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.